VERU has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
VERU has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Veru's Accumulated other comprehensive income (loss) for the quarter that ended in Dec. 2023 was $-0.58 Mil.
Veru's quarterly Accumulated other comprehensive income (loss) stayed the same from Jun. 2023 ($-0.58 Mil) to Sep. 2023 ($-0.58 Mil) and stayed the same from Sep. 2023 ($-0.58 Mil) to Dec. 2023 ($-0.58 Mil).
Veru's annual Accumulated other comprehensive income (loss) stayed the same from Sep. 2021 ($-0.58 Mil) to Sep. 2022 ($-0.58 Mil) and stayed the same from Sep. 2022 ($-0.58 Mil) to Sep. 2023 ($-0.58 Mil).
The historical data trend for Veru's Accumulated other comprehensive income (loss) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Veru Annual Data | |||||||||||||||||||||
Trend | Sep14 | Sep15 | Sep16 | Sep17 | Sep18 | Sep19 | Sep20 | Sep21 | Sep22 | Sep23 | |||||||||||
Accumulated other comprehensive income (loss) | Get a 7-Day Free Trial | -0.58 | -0.58 | -0.58 | -0.58 | -0.58 |
Veru Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Accumulated other comprehensive income (loss) | Get a 7-Day Free Trial | -0.58 | -0.58 | -0.58 | -0.58 | -0.58 |
Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.
Thank you for viewing the detailed overview of Veru's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.
Mario Eisenberger | director | 515 N. STATE STREET, SUITE 2225, C/O THE FEMALE HEALTH COMPANY, CHICAGO IL 60654 |
Lucy Lu | director | THE FEMALE HEALTH COMPANY, 4400 BISCAYNE BOULEVARD, SUITE 888, MIAMI FL 33137 |
Harry Fisch | director, 10 percent owner | 515 N. STATE STREET, SUITE 2225, C/O THE FEMALE HEALTH COMPANY, CHICAGO IL 60654 |
Grace Hyun | director | 48 NW 25TH STREET, SUITE 102, MIAMI FL 33127 |
Mitchell Shuster Steiner | director, 10 percent owner, officer: President and CEO | 175 TOYOTA PLAZA, 7TH FLOOR, MEMPHIS TN 38103 |
K Gary Barnette | officer: Chief Scientific Officer | 4400 BISCAYNE BOULEVARD, SUITE 888, MIAMI FL 33137 |
Michele Greco | officer: VP and CFO | 515 NORTH STATE STREET, SUITE 2225, CHICAGO IL 60654 |
Jesus Socorro | director | 4400 BISCAYNE BOULEVARD, SUITE 888, MIAMI FL 33137 |
Todd Charles T Jr | officer: CEO of FHC Division | 4400 BISCAYNE BOULEVARD, SUITE 888, MIAMI FL 33137 |
Michael L Rankowitz | director | 2500 LAKE COOK ROAD, RIVERWOODS IL 60015 |
Robert Getzenberg | officer: Chief Scientific Officer | 4400 BISCAYNE BOULEVARD, SUITE 888, MIAMI FL 33137 |
Elgar Peerschke | director | 515 N. STATE STREET, SUITE 2225, C/O THE FEMALE HEALTH COMPANY, CHICAGO IL 60654 |
Daniel Haines | officer: CFO and COO | 515 N. STATE STREET, SUITE 2225, C/O THE FEMALE HEALTH COMPANY, CHICAGO IL 60654 |
David R Bethune | director | THE FEMALE HEALTH COMPANY, 515 NORTH STATE STREET, SUITE 2225, CHICAGO IL 60610 |
O B Parrish | director, officer: Chairman/Chief Exec. Officer |
From GuruFocus
By sperokesalga sperokesalga • 05-04-2023
By sperokesalga sperokesalga • 05-24-2023
By Stock market mentor Stock market mentor • 02-05-2023
By PRNewswire PRNewswire • 02-02-2023
By PRNewswire • 11-19-2023
By Marketwired • 06-21-2023
By Marketwired • 08-10-2023
By Marketwired • 09-11-2023
By Business Wire Business Wire • 02-02-2023
By Marketwired • 08-30-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.